What sets Rischling apart is her holistic approachcombining functional medicine with advanced therapies like peptides
A 2007 double-blind, multicenter trial (n=102) showed ALC 1,500 mg/day significantly improved tender point count, total myalgic score, depression, and musculoskeletal pain compared to placebo.[9] A 2015 RCT found ALC 1,500 mg/day comparable to duloxetine 60 mg/day for pain and depression.[8] Most notably, a 2023 RCT demonstrated that adding PEA 1,200 mg/day + ALC 2,000 mg/day to ongoing duloxetine + pregabalin therapy produced significantly greater improvements in Widespread Pain Index, FIQR, and FASmod scores.[7] Role in Treatment: ALC can be used as monotherapy or adjunctive therapy in fibromyalgia
All research peptides Final disclaimer: This product description is for educational and informational purposes only and is not medical advice
IGF-1 LR3 Dosing | Verdict We have put together this informative guide for researchers interested in calculating the proper IGF-1 LR3 dosage for their next study
100011140650 Effective until 13/06/2027 ACTIVITE (L-GLUTATHIONE WITH L-CYSTEINE, ALPHA-LIPOIC ACID AND NIACINAMIDE CAPSULE DIETARY SUPPLEMENT) (Giffarine Brand) CICOT.HL